The sliding filament theory of muscle contraction is widely accepted as the means by 15 which muscles generate force during activation. Within the constraints of this theory, isometric, 16 steady-state force produced during muscle activation is proportional to the amount of filament 17 overlap. Previous studies from our laboratory demonstrated enhanced titin-based force in 18 myofibrils that were actively stretched to lengths which exceeded filament overlap. This 19 observation cannot be explained by the sliding filament theory. The aim of the present study was 20 to further investigate the enhanced state of titin during active stretch. Specifically, we confirm 21 that this enhanced state of force is observed in a mouse model and quantify the contribution of 22 calcium to this force. Titin-based force was increased by up to four times that of passive force 23 during active stretch of isolated myofibrils. Enhanced titin-based force has now been 24 demonstrated in two distinct animal models, suggesting that modulation of titin-based force 25 during active stretch is an inherent property of skeletal muscle. Our results also demonstrated 26 that 15% of titin's enhanced state can be attributed to direct calcium effects on the protein, 27 presumably a stiffening of the protein upon calcium binding to the E-rich region of the PEVK 28 segment and selected Ig domain segments. We suggest that the remaining unexplained 85% of 29 this extra force results from titin binding to the thin filament. With this enhanced force confirmed 30 in the mouse model, future studies will aim to elucidate the proposed titin-thin filament 31 interaction in actively stretched sarcomeres. 32 33 34 35 36 37 38
INTRODUCTION 40
The current, and generally accepted, theory which explains active force production in 41 muscle is the sliding filament-based cross-bridge model. This model predicts that active force is 42 produced when cross-bridges cyclically form between the thick and thin filaments in the 43 sarcomere (Huxley and Simmons, 1971) . Therefore, for a given level of activation, the isometric 44 steady-state force generated by an active muscle should be proportional to the number of cross-45 bridges that can form, which corresponds to the amount of overlap between the thick and thin 46 filaments (Gordon et al., 1966; Huxley and Niedergerke, 1954) . This constitutes the force-47 sarcomere length relationship, which is generally adhered to during isometric contractions 48 (Gordon et al., 1966) . However, following eccentric, or lengthening, contractions the isometric 49 steady-state force produced at a given sarcomere length exceeds the predictions of the force- Rassier, 2012) . There are three main filaments at the sarcomere level that contribute to force 56 production in muscle: the thick (myosin), the thin (actin), and the titin filaments. The thick 57 filament is comprised primarily of the protein myosin and the thin filament is comprised of actin 58 and regulatory proteins. Interactions between the thick and thin filaments are understood to 59 generate active force during muscle contraction. Titin is a spring-like protein that produces 60 passive force when sarcomeres are stretched beyond a certain resting length. With increased 61 stretch on the descending limb of the force-sarcomere length relationship, the contribution of 62 titin to the total force produced increases exponentially (Granzier and Labeit, 2004) . In an 63 attempt to explain how sarcomeres can produce force beyond what is provided by the 64 interactions between thick and thin filaments, it has been suggested that residual force 65 enhancement may be the result of a passive element becoming 'engaged' during active stretch 66 The Journal of Experimental Biology -ACCEPTED AUTHOR MANUSCRIPT enhancement increases with increased magnitude of stretch and is greater as the muscle is 70 stretched further on the descending limb of the force-length relationship (Edman et al., 1982) . 71
Additional studies have observed enhanced passive force in muscles following active stretch 72 (Herzog and Leonard, 2002; Joumaa et al., 2008; Labeit et al., 2003) , alluding to a passive 73 element in the property of force enhancement 74
Titin is the primary contributor to passive force at the myofibrillar level (Wang et al., 75 1991) . Titin is a dynamic protein that contributes to many different aspects of muscle function, 76
including passive force production (28), myofibrillar assembly (Gregorio et al., 1999) , centering 77 of the thick filament (Horowits and Podolsky, 1987) , sarcomere stability (Herzog et al., 2012c) , 78 and various signaling events (Granzier and Labeit, 2004) . Titin is functionally separated into a 79 structural A-band and an extensible I-band region ( The configuration of titin's extensible I-band is changed in the presence of calcium (Tatsumi et 93 al., 2001) . Specifically, it has been shown that the stiffness of titin's I-band region increases 94 when calcium ions bind to the PEVK region and Ig domains (DuVall et al., 2013; Labeit et al., 95 2003) . In addition to intrinsic changes to the stiffness of titin, calcium-dependent interactions 96 between titin and the thin filament have also been observed (Kellermayer and Granzier, 1996) . 97
These observations support the speculation that titin may be engaged during active stretch 98 Recently, investigated modulation of titin-based force during 101 active stretch beyond filament overlap. The findings of that study indicated that the increase in 102 titin-based stiffness must employ an additional mechanism other than calcium to produce the 103 increase in force that was observed since no effect of calcium activation, in the absence of cross-104 bridge-based active forces, was observed. They speculated that modulation of titin-based force 105 may occur when titin binds to the thin filament during strong cross-bridge binding to actin 106 . While titin binding to the thin filament has been previously 107 differences in phenotype between mdm and wild-type mice, it remains unclear how the mdm 119 mutation affects titin functionally. However, whole muscle experiments demonstrate that 120 modulation of titin-based stiffness does not occur in mdm soleus during calcium activation 121 (Nishikawa et al., 2012) , thereby suggesting the possibility that modulation of titin-based force 122 occurs within the deleted region of mdm titin. We would like to investigate this possibility. 123
However, prior to embarking on such experiments, the properties of titin-based force 124 enhancement in actively stretched muscles need to be confirmed in the mouse model, and the 125 contribution of calcium activation in the absence of cross-bridge-based active forces on titin's 126 stiffness and force need to be carefully determined. 127
The purpose of this study was to determine whether modulation of titin-based force 128 during active stretch occurs in the wild-type, or normal, mouse and to quantify the effects of 129 calcium activation on titin stiffness to further elucidate the mechanism of titin-based force 130
The Journal of Experimental Biology -ACCEPTED AUTHOR MANUSCRIPT enhancement during active stretch. Enhanced titin-based force with active stretch has only been 131 directly observed in experiments using rabbit psoas myofibrils and 132 needs to be confirmed in another animal model, as was previously suggested (Granzier, 2010) . In 133 addition, the experiments by Leonard & Herzog were unable to resolve an effect of calcium on 134 the increase in stiffness of titin, possibly due to the high variation of their data. This is surprising 135 as calcium has been shown to increase the stiffness of titin (DuVall et al., 2013; Joumaa et al., 136 2008; Labeit et al., 2003) . Thus, this study specifically aimed to quantify the contribution of 137 calcium effects to titin's enhanced force. We hypothesized that titin-based stiffness would be 138 increased in actively stretched mouse skeletal muscle and that the increase in stiffness would not 139 be explained entirely by the effects of calcium on titin stiffness. 140
RESULTS 141
The steady state force following stretch was greater in active than passive experiments 142 ( Fig. 3A ). Individual sarcomere lengths were measured at the end of stretch in a subset of three 143 active and three passive experiments to ensure that filament overlap was lost in all sarcomeres. 144
Although sarcomere length non-uniformities were present, all measured sarcomeres were beyond 145 filament overlap at the end of stretch ( Calcium activated myofibrils produced more force during stretch compared to passive, 149 cross-bridge inhibited (BDM), and TnC-depleted myofibrils at all measured sarcomere lengths 150 (2.5-6.0 µm) (p < 0.01) ( Fig. 4 ). Therefore, calcium activated myofibrils produced more force 151 both within the region of filament overlap (< 4.0 µm) and beyond the region of thick-thin 152 filament overlap (~4.0-6.0 µm) in mouse psoas myofibrils that were either not activated, or were 153 activated but force production was prevented, either by depletion of a regulatory protein (TnC) 154 or by inhibiting strong cross-bridge binding (BDM). 155 BDM treated and TnC-depleted myofibrils produced significantly less force than calcium 156 activated myofibrils at all sarcomere lengths (p < 0.01). However, they produced more force than 157 the passively stretched myofibrils across all sarcomere lengths exceeding 3.5µm (p < 0.05) ( Fig.  158 4). For sarcomere lengths beyond myofilament overlap, the force increase in BDM treated and 159
TnC-depleted myofibrils averaged approximately 15% of the total increase observed in the 160 normal (non-inhibited) myofibrils. BDM treated and TnC-depleted myofibrils did not differ in 161 force at any sarcomere lengths. 162
Simulations using a three-filament model (Schappacher-Tilp et al., submitted 2014) 163 assumed that titin's N2A region binds to the thin filament leaving only the PEVK region and the 164 distal Ig domains as free spring elements ( Fig.5 ). Forces predicted in actively stretched 165 sarcomeres with N2A thin-filament binding exceeded passive force predictions. Forces predicted 166 for actively stretched sarcomeres without N2A thin-filament binding were deficient in titin-based 167 force enhancement. There was a small increase in predicted force between actively (without N2A 168 thin-filament binding) and passively stretched myofibrils (~12%). Predicted force-elongation 169 curves of actively stretched sarcomeres without N2A thin-filament binding closely resembled 170
TnC-depleted and BDM treated experimental observations. 171
DISCUSSION 172
The first aim of this study was to determine whether titin-based force is increased during 173 active compared to passive stretch of mouse skeletal muscle myofibrils. Previous experiments in 174 rabbit psoas myofibrils showed that at lengths beyond filament overlap, titin-based force is much 175 greater in active compared to passive stretching. The increase in titin-based force from these 176 studies could not be explained with any known mechanism of sarcomere force modulation 177 . The results from the present study demonstrate that titin-based 178 force is also greater during active compared to passive stretch in mouse psoas myofibrils. This 179 modulation of titin force allows the sarcomere to maintain its force-generating capability during 180 active stretch to lengths beyond filament overlap and provides a protective mechanism within the 181 sarcomere by which active stretch is limited. 182
In actively stretched mouse psoas myofibrils, forces exceeded the force observed in 183 passively stretched myofibrils matched at all sarcomere lengths. One would expect that at 184 sarcomere lengths within filament overlap (< 4.0 µm), calcium activated myofibrils produce 185 more force than non-activated myofibrils because of the active forces produced by cross-bridge 186 interactions between the contractile filaments actin and myosin. However, cross-bridge forces 187 cannot be used to explain the increase of force production in calcium activated myofibrils that 188 are stretched beyond filament overlap (> 4.0 µm) . At these lengths, 189
The Journal of Experimental Biology -ACCEPTED AUTHOR MANUSCRIPT cross-bridges cannot form and titin is virtually the exclusive contributor to myofibril force 190 (Herzog et al., 2012b). 191 It is well-known that sarcomeres in muscles (Llewellyn et al., 2008) , fibers (Page and 192 Huxley, 1963) and TnC-depletion were conducted to potentially identify the mechanisms underlying the 215 observed increase in titin-based stiffness in actively stretched myofibrils. TnC-depleted 216 myofibrils can be calcium activated but produce no active force as calcium binding to the 217 regulatory TnC protein is not possible, thus the binding site of the cross-bridge on actin remains 218 inaccessible to cross-bridges (Moss et al., 1985) . Similarly, BDM treated myofibrils can be 219 calcium activated, and allow for cross-bridge binding to actin in the weakly bound state, but 220 BDM prevents phosphate release from the nucleotide pocket of the cross-bridge, thereby 221 inhibiting strong cross-bridge binding (Tesi et al., 2002) . At sarcomere lengths beyond 222 myofilament overlap (4.0-6.0 µm), calcium activation in BDM treated and TnC-depleted 223 myofibrils increased titin force by approximately 15% of the total increase observed in actively 224 (but non-force inhibited) compared to passively stretched myofibrils. Therefore, it appears that 225 although calcium activation provides increased stiffness to titin, and thus increased force upon 226 sarcomere stretching, this effect is minimal. The full amount of increased titin-based force, 227 which we will refer to as "titin-based force enhancement" requires active force production and 228 strong cross-bridge binding to actin. 229
Interestingly, the myofibril forces in BDM treated and TnC-depleted myofibrils were the 230 same when sarcomeres were stretched beyond filament overlap. In TnC-depleted myofibrils, 231
there is thought to be no cross-bridge attachment to actin, and titin-enhancement is small, as 232 shown above. In BDM treated myofibrils, weak cross-bridge binding is thought to occur, and 233 small configurational changes in the regulatory proteins troponin and tropomyosin would be 234 expected, but even these events do not produce titin force beyond that observed in the TnC-235 depleted myofibrils. Thus, weak cross-bridge binding and some configurational changes in the 236 regulatory proteins do not seem sufficient to allow for the full titin-based force enhancement 237 observed in intact, non-inhibited actively stretched myofibrils. 238
If calcium activation alone is not sufficient to explain the increase in titin stiffness during 239 active stretch, an additional mechanism by which titin-based force is enhanced during active 240 stretch must be at work. Of the various known mechanisms by which titin-based stiffness can be 241 rapidly and reversibly adjusted, we are currently unaware of any mechanism by which titin 242 stiffness is increased by up to 400%. Therefore, we are of the impression that the titin spring 243 must become shorter in actively stretched sarcomeres to explain our findings. It was recently 244 hypothesized that titin-based force may be enhanced when cycling cross-bridges both translate 245 and rotate the thin filaments, winding titin upon the thin filament during activation (Nishikawa et 246 al., 2012) . While logistically discreet, this hypothesis conceptually aligns with our assumption 247 that the available spring length of titin must decrease in actively stretched sarcomeres. 248
Shortening of the titin spring could occur by any number of mechanisms. However, the simplest 249
The Journal of Experimental Biology -ACCEPTED AUTHOR MANUSCRIPT way to explain titin-based force enhancement is by assuming that titin binds to the thin filament 250 when cross-bridges bind strongly to the thin filament. Thin-filament-titin interactions are well 251 documented in cardiac muscle (Kellermayer and Granzier, 1996) , however, much less is known 252 concerning the interaction between skeletal muscle titin and the thin filament. We acknowledge 253 the vast possibilities by which titin-thin filament interactions could increase the stiffness of titin 254 and the precise location and characteristics of this mechanism will require further investigations. 255
We previously proposed that a binding site for titin on the thin filament may be exposed 256 during the movement of regulatory proteins with the influx of calcium (Herzog et al., 2012a; 257 Herzog et al., 2012c; . However, the results from the present study 258 suggest that movement of regulatory proteins is not sufficient to initiate titin-based force 259 enhancement. This is because there was no difference in force between TnC-depleted myofibrils 260 (no movement of regulatory proteins) and BDM treated myofibrils (presumed movement of 261 regulatory proteins). Therefore, we now speculate that with the influx of calcium and the 262 initiation of cross-bridge cycling, one (or many) site(s) on the thin filament are exposed, 263 allowing titin-thin filament binding to decrease the available spring length of titin in an activated 264 sarcomere (Fig. 6 ). This hypothesis is particularly attractive as it provides an energetically 265 efficient and reversible mechanism by which titin-based force could be modulated during 266 activation. Experimental support for titin-thin filament interactions is provided by experiments in 267 rabbit longissimus dorsi muscle, which demonstrate calcium-dependent changes in titin-actin 268 interactions. In these studies an unidentified segment of titin demonstrated binding to actin 269 filaments in a calcium-dependent manner (Kellermayer and Granzier, 1996) . While this segment 270 of titin has not been identified, these results provide support for the idea that titin may bind to the 271 thin filament during calcium-activation. 272
Recent speculation that the N2A segment of titin may be the site of thin filament-titin 273 binding (Nishikawa et al., 2012) provides the basis for a focused investigation. The N2A 274 segment of titin has a mechanical role in passive skeletal muscle, resisting stretch at long 275 sarcomere lengths (Granzier and Labeit, 2004) and is also a main player in numerous skeletal 276 muscle signaling events (Huebsch et al., 2005) . Binding at the N2A segment of titin would be 277 mechanically advantageous as it would prevent the proximal Ig domain from extending upon 278 stretch ( Fig. 6 ) and allow the high-force PEVK region to be recruited immediately upon stretch 279 (Nishikawa et al., 2012) . The hypothesis that N2A titin is the site of titin-thin filament binding is 280 based on studies in the mdm mouse model, which is characterized by a deletion in the N2A 281 region of titin (Garvey et al., 2002) . During active unloading of whole mouse soleus muscles, the 282 titin spring is shorter and stiffer than in passive soleus muscles while no change in length or 283 stiffness is observed in soleus muscles of mdm mice during active unloading (Monroy et al., 284 2012 ). These results suggest that the mechanism by which titin achieves an enhanced state of 285 stiffness during calcium activation is altered in mdm titin. Further support for N2A as the site of 286 titin-thin filament binding is provided by reports that suggest a fundamental difference in titin-287 actin interactions between skeletal muscle that expresses N2A titin and cardiac muscle that 288 expresses N2B (Yamasaki et al., 2001) . 289
To investigate this hypothesis further, we modeled the proposed N2A titin-thin filament 290 interaction to determine whether this mechanism could explain titin-based force enhancement. 291
We assumed that titin's N2A region binds to the thin filament leaving only the PEVK region and 292 the distal Ig domains as free spring elements. While the predicted absolute values of stress based 293 on the rabbit psoas model differ from the experimental results from mouse, we can study the 294 impact of N2A-thin filament binding on force predictions conceptually (Fig. 5 ). Forces predicted 295 during actively stretched sarcomeres with N2A thin-filament binding show a substantial force 296 gain at long sarcomere lengths vastly exceeding purely passive forces and forces predicted for 297 activation without N2A binding. With N2A-thin filament binding, titin-based force predicted by 298 the model was doubled in actively stretched sarcomeres. Experimental results demonstrate 3-4 299 times greater titin-based force in actively stretched mouse psoas myofibrils and approximately 3 300 times greater in rabbit psoas myofibrils (Leonard and Herzog, 2010) which exceeds the force 301 predicted by the model. By shifting the binding site on titin towards the M-line, the force gain 302 would be substantially higher; suggesting that the binding site on titin would be located at or 303 distal to the N2A segment. When simulations were performed in the absence of N2A-thin 304 filament binding, the model predictions of titin-based force coincided closely with cross-bridge 305 inhibited (TnC-depleted and BDM) sarcomeres, which were deficient in titin-based force 306 enhancement (Fig. 4) . The predicted force of actively stretched myofibrils without titin binding 307 still exceeded passive forces, presumably due the binding of calcium to the PEVK and Ig proposed mechanism that titin is bound to the thin filament during activation. To reproduce the 311 absolute values of the experimental results one might need to fit the parameters for the mouse 312 model. Nevertheless, the conceptual premise of the results observed in mouse myofibrils 313 supports titin binding to the thin filament at or distal to the N2A segment. 314
With the enhanced force of titin confirmed in the mouse skeletal muscle, future 315 experiments can utilize the mdm model to further investigate the role of N2A titin in titin-based 316 force enhancement. In a preliminary investigation, we isolated and stretched calcium activated 317 and non-activated mdm myofibrils using the same experimental protocol described below to 318 determine whether the mdm deletion in N2A titin affects titin-based force enhancement. Isolated 319 mdm myofibrils did not differ in diameter or structure and thus were expected to contain the 320 same quantity of contractile material and force-producing capability as in wild-type myofibrils. 321
Despite our expectations, when activated at the plateau of the force-length relationship, 322 contraction force was decreased in mdm compared to wild-type myofibrils activated at 323 corresponding sarcomere lengths. During active stretch, titin-based force enhancement was 324 present in mdm (Fig. 7) but to a much lesser extent than in actively stretched wild-type 325 myofibrils (Fig 4) , suggesting that titin-based force enhancement is affected by the mdm 326 deletion. These pilot results are in accordance with the proposed mechanism that N2A titin binds 327 to the thin filament to achieve enhanced force during active stretch; however, additional 328 experiments and considerations are required in the interpretation of these results. Whether N2A 329 is the site of titin that binds to the thin filament during calcium activation will require a more 330 focused investigation. Nevertheless, this preliminary data is a strong indication that N2A titin is 331 a binding site or otherwise involved in the mechanism of titin-based force enhancement. 332
When considering an interaction between titin and the thin filament in explaining 333 enhanced titin-based force during active stretch, it is important to consider that with the 334 exception of calcium stiffening of titin, titin-based force enhancement was abolished when 335 strong cross-bridge cycling was inhibited. This result suggests that titin's enhanced state is at 336 least in part dependent on the presence of cross-bridge cycling and active force. Previous results 337 from rabbit psoas myofibrils showed that titin-based force enhancement was decreased when the 338 myofibril was activated at long sarcomere lengths, with less than optimal filament overlap 339 . If titin-thin filament interactions are partially responsible for the enhancement of titin-based force, these results would suggest that the interaction occurs with the 341 onset of cross-bridge cycling, and thus, at sarcomere lengths where initial activation occurs. This 342 indicates that titin's contribution to the force produced during active stretch spans the full length 343 of stretch. While the present study could not disseminate any contribution of titin to active force 344 within the region of overlap, the question of whether titin contributes to the force generated 345 within the region of overlap during active stretch is an important topic for future studies. contribute to the resistive force limiting sarcomere stretch within a muscle fiber, our results 361 indicate that titin-based force enhancement is a fundamental mechanical property of the 362 sarcomeres themselves, which provides an inherent resistance to actively stretching sarcomeres. 363
In summary, we found that titin-based force is increased in actively stretched mouse 364 psoas myofibrils at lengths beyond filament overlap. With studies from rabbit and mouse 365 demonstrating this property, we propose that enhanced titin-based force beyond the effects of 366 calcium is an inherent property of actively stretched skeletal muscle. Calcium activation alone 367 could only explain 15% of the increase in titin-based force beyond filament overlap; therefore we 368 propose that with the onset of cross-bridge cycling and active force, titin binds to the thin 369 filament and decreases its available spring length resulting in a drastic increase in its spring 370
The Journal of Experimental Biology -ACCEPTED AUTHOR MANUSCRIPT stiffness. This mechanism would provide the sarcomere with an additional source of force 371 production during active stretch, which could potentially provide an explaination for how 372 skeletal muscles achieve enhanced force following active stretch. While additional experiments 373 are needed to elucidate the mechanism by which titin-based force enhancement occurs, our 374 results suggest that it is initiated when a site on titin (at or distal to the N2A segment) binds to 375 the thin filament with the onset of cross-bridge cycling. With past and present studies 376 demonstrating a role for titin in active muscle, our understanding of force production should 377 begin to expand the contribution of titin in actively stretched skeletal muscle. 378
MATERIALS AND METHODS 379

Sample Preparations 380
A myofibril is the smallest structural unit of muscle that maintains the natural 381 architecture of the contractile apparatus (Yang et al., 1998) . In a single myofibril, extracellular 382 connective tissues are absent and all force measured must be generated by the proteins 383 comprising sarcomeres in series. Therefore, myofibril experiments are ideal for the investigation 384 of the contribution of titin to force production in sarcomeres as described previously (Leonard 385 and . 386
Experiment setup 387
All tests were conducted using an inverted microscope (Zeiss Axiovert 200M) equipped 388 with a ×100 oil immersion objective (numerical aperture 1.3) with a ×2.5 Optovar (Leonard and 389 Herzog, 2010) under ×100 oil immersion. 390
Myofibril forces were determined using custom-built nanofabricated silicon nitride 391 cantilevers with two arms and a stiffness of 21 or 68 pN/nm (Fig. 2) . Myofibrils were glued 392 (Dow Corning 3145) to one of the lever arms at one end and wrapped around a stiff glass needle 393 at the other end. Displacement of one cantilever arm attached to the myofibril relative to the 394 second reference arm was measured using a custom MATLAB program. Force was calculated 395 from the measured displacement and the known lever stiffness and expressed in units of stress 396 (nN/μm 2 ) by normalizing the measured force to the cross-sectional area of each myofibril. 397
Materials 398
Strips of mouse psoas muscle were extracted from euthanized animals and tied to wooden 399 strips to preserve the in situ length. The muscle strips were placed in a rigor-glycerol solution (-400 20°C, pH 7.0) with protease inhibitors (Complete®, Roche Diagnostics, Montreal, QB, Canada) 401 and stored at -20°C for 12-17 days . For experiments, muscle strips 402 were homogenized in a rigor solution at 4°C and tested at 20°C . 403
Activation of myofibrils was achieved by direct application of calcium ions in an activation 404 solution (pCa 3.5) . Ethics approval was granted by the Life and 405
Environmental Sciences Animal Ethics Committee of the University of Calgary. 406
Experimental Protocol 407
Single myofibrils with four to twelve sarcomeres in series were mounted between a 408 needle for controlled length changes and a cantilever to measure force (Fig. 3) . Myofibril lengths 409 were adjusted to an initial average sarcomere length of 2.5 and myofilament overlap in mouse psoas would be expected to be lost at sarcomere lengths of 415 approximately 3.95 µm (Herzog et al., 1992) . Therefore, when the average sarcomere lengths 416 within a myofibril exceed 4.0 µm, we can safely assume that some sarcomeres and half-417 sarcomeres are pulled beyond myofilament overlap, and thus their forces, which are strictly in 418 series with the rest of the myofibril, have to match those produced in the remaining sarcomeres. The inclusion criterion for successful myofibril experiments were determined and strictly 427 adhered to. A myofibril experiment was considered successful if (1) all sarcomeres lengthened 428 and (2) the force increased with stretch for the entire duration of stretch. In actively stretched 429 myofibril experiments, in addition to the two criteria stated above, all sarcomeres had to visibly 430 shorten upon activation for the experiment to be considered viable. All experiments which did 431 not exhibit the established criterion were excluded from statistical analyses. 432
Experimental Groups 433
Group 1 -passive: myofibrils (n = 10) were passively stretched in a non-activating (pCa 434 The TnC-depletion protocol used in this study has been described previously and its 444 effectiveness in eliminating TnC from actin, thereby preventing any cross-bridge based forces, 445 has been verified using gel electrophoresis and force measurements, respectively (Joumaa et al., 446 2008) . 447
Group 4 -BDM: myofibrils (n = 8) were stretched in a calcium-ATP activation solution 448 with 20nM butanedione monoxime (BDM), an inhibitor of strong cross-bridge binding to actin 449 (Tesi et al., 2002) . All solutions used in this study have been previously published (Joumaa et al., 450 2008; . 451
Modeling 452
The proposed N2A titin-thin filament interaction was simulated to determine whether it 453 could explain titin-based force enhancement in previous and present 454 following chemical depletion of troponin-C (TnC-X, triangles), and in a low Ca 2+ relaxing 517 solution (passive, circles). Activated myofibrils generated significantly more force than BDM, 518
TnC-X, and Passive myofibrils at all sarcomere lengths both within and beyond the region of 519 filament overlap (p < 0.01). BDM and TnC-X myofibrils generated significantly more force than 520 passive myofibrils at average sarcomere lengths of 3.5 -6.0 µm (p < 0.01). 521 Myofibrils were stretched from an average initial sarcomere length of 2.5 µm to an average final 542 sarcomere length of 6.0 µm. The loss of filament overlap is designated by the dotted line. The 543 force of activated mdm myofibrils (triangle) remains higher than the force of the non-activated 544 mdm myofibrils (blue) for the duration of stretch. Titin-based force was increased during active 545 stretch, but to a lesser extent than in actively stretched wild-type myofibrils (Fig. 3) . 
